New shot aims to tame genital herpes outbreaks

NCT ID NCT05298254

Completed Disease control Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

Summary

This study tested a new immunotherapy designed to help the body's immune system fight the herpes virus. It involved 505 healthy adults and adults with recurrent genital herpes to check for safety and see if the treatment could reduce outbreaks and viral shedding. The goal is to better control the infection, not to cure or prevent initial infection.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

GSK Investigational Site

Phoenix, Arizona, 85015, United States
GSK Investigational Site

Wichita, Kansas, 67207, United States
GSK Investigational Site

Kansas City, Missouri, 64114, United States
GSK Investigational Site

Rochester, New York, 14609, United States
GSK Investigational Site

Richmond, Virginia, 23219, United States
GSK Investigational Site

Seattle, Washington, 98105, United States
GSK Investigational Site

Darlinghurst, New South Wales, 2010, Australia
GSK Investigational Site

Sydney, New South Wales, 2010, Australia
GSK Investigational Site

Antwerp, 2000, Belgium
GSK Investigational Site

Brussels, 1000, Belgium
GSK Investigational Site

Edegem, 2650, Belgium
GSK Investigational Site

Ghent, 9000, Belgium
GSK Investigational Site

Montreal, Quebec, H2L 4E9, Canada
GSK Investigational Site

Tartu, 50106, Estonia
GSK Investigational Site

Berlin, 10117, Germany
GSK Investigational Site

Berlin, 10439, Germany
GSK Investigational Site

Bochum, 44787, Germany
GSK Investigational Site

Cologne, 50674, Germany
GSK Investigational Site

Frankfurt, 60596, Germany
GSK Investigational Site

Hamburg, 20146, Germany
GSK Investigational Site

Barcelona, 08001, Spain
GSK Investigational Site

Barcelona, 08015, Spain
GSK Investigational Site

Madrid, 28010, Spain
GSK Investigational Site

Madrid, 28040, Spain
GSK Investigational Site

Madrid, 28222, Spain
GSK Investigational Site

Marbella, 29600, Spain
GSK Investigational Site

Brighton, BN2 1ES, United Kingdom
GSK Investigational Site

Liverpool, L7 8XP, United Kingdom
GSK Investigational Site

London, WC1E 6JB, United Kingdom
GSK Investigational Site

Southampton, SO14 0YG, United Kingdom

Conditions

Explore the condition pages connected to this study.

HERPES SIMPLEX